Education
About Us
Working with TipRanks
Follow Us
Photocure ASA (PHCUF)
OTHER OTC:PHCUF
PHCUF Stock Chart & Stats
$6.34
$0.17(3.46%)
At close: 4:00 PM EST
$6.34
$0.17(3.46%)
Day’s Range― - ―
52-Week Range$4.00 - $6.82
Previous CloseN/A
Volume400.00
Average Volume (3M)5.00
Market Cap
$172.01M
Enterprise Value$1.21B
Total Cash (Recent Filing)$259.54M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)1243.1
Beta0.40
Next Earnings
Feb 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding27,120,820
10 Day Avg. Volume0
30 Day Avg. Volume5
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap7.05
Enterprise Value/Revenue2.28
Enterprise Value/Gross Profit2.46
Enterprise Value/Ebitda19.74
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Photocure ASA News
PHCUF FAQ
What was Photocure ASA’s price range in the past 12 months?
Photocure ASA lowest stock price was $4.00 and its highest was $6.82 in the past 12 months.
What is Photocure ASA’s market cap?
Photocure ASA’s market cap is $172.01M.
When is Photocure ASA’s upcoming earnings report date?
Photocure ASA’s upcoming earnings report date is Feb 25, 2026 which is in 81 days.
How were Photocure ASA’s earnings last quarter?
Photocure ASA released its earnings results on Oct 29, 2025. The company reported $0.015 earnings per share for the quarter, beating the consensus estimate of -$0.007 by $0.022.
Is Photocure ASA overvalued?
According to Wall Street analysts Photocure ASA’s price is currently Overvalued.
Does Photocure ASA pay dividends?
Photocure ASA does not currently pay dividends.
What is Photocure ASA’s EPS estimate?
Photocure ASA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Photocure ASA have?
Photocure ASA has 27,120,820 shares outstanding.
What happened to Photocure ASA’s price movement after its last earnings report?
Photocure ASA reported an EPS of $0.015 in its last earnings report, beating expectations of -$0.007. Following the earnings report the stock price went up 1.304%.
Which hedge fund is a major shareholder of Photocure ASA?
Currently, no hedge funds are holding shares in PHCUF
Company Description
Photocure ASA
Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the Netherlands, Italy, other European Countries, and the United States. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus infection and precancerous lesions of the cervix. The company sells its products to pharmaceutical wholesalers, pharmacies, and hospitals through license partners. Photocure ASA was founded in 1993 and is headquartered in Oslo, Norway.
PHCUF Company Deck
PHCUF Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted Photocure's strong product growth, strategic market expansions, and positive financial performance, despite challenges in the Flex segment and foreign exchange impacts. The company is well-positioned for future growth with innovative partnerships and a strong cash flow position.View all PHCUF earnings summariesTechnical Analysis
Catalyst Pharma
―
Eagle Pharmaceuticals
―
Omeros
―
Tonix Pharma
―
Oncolytics Biotech
―
Pfizer
―
Ownership Overview
―
Insiders
0.10% Mutual Funds
― Other Institutional Investors
99.65% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---